BioProcess International reviews key biotech trends from the first half of 2026, including US onshoring, China's biologics ...
Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...
New York invests $65M in biotech with new clinical trial consortium and Biogenesis Park to compete with Boston, San Francisco ...
Beyond Installation, Operational, and Performance Qualifications: A Risk-Based Validation Framework for AI-Driven Software in ...
Pierre-Alain Ruffieux of Cytiva discusses key biotech trends including new modalities, AI adoption, supply chain stability, ...
Clinigen's Jules Shale discusses navigating complex logistics to deliver life-saving therapies and the rewarding human ...
AstraZeneca reports 88% emissions cut since 2015, crediting AI for accelerating drug discovery while embedding sustainability ...
Rentschler Biopharma, Syngene, and Symeres announce major leadership changes, appointing new CEOs and executives to drive ...
Sivakumar Kalidoss, BPI contributor ...
VectorBuilder made an agreement with MaxCyte, a biotechnology and electroporation company. The partnership will focus on ...
AGC Biologics and Pyramid Pharma Services partner to offer integrated drug development and fill-finish services for US-based biopharmaceutical clients.
Sartorius and LFB Biomanufacturing expand their CDMO partnership, integrating engineered CHO cell lines with GMP manufacturing capabilities.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results